Pay in 4 interest-free payments of $7.20 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Semaglutide is an FDA-approved GLP-1 receptor agonist for weight management, backed by the large STEP trial program
We'll review your goals and health history and discuss whether a supervised protocol is appropriate for you
The capsule formulation guarantees the integrity of the active ingredient
While faster weight loss can be normal at the beginning, extremely rapid loss should be monitored to ensure muscle mass and nutrition are maintained
Whole-Body Benefits Because GLP-1 also improves cardiovascular health and reduces inflammation, supporting your natural production contributes to long-term wellness, not just short-term blood sugar fixes
SYNERGY-NASH: Tirzepatide and metabolic steatohepatitis (MASH) SYNERGY-NASH (Loomba et al., NEJM 2024, NEJMoa2401943, PMID 38856224) is a phase 2 trial in 190 patients with metabolic steatohepatitis (MASH) and biopsy-proven stage 2 or 3 fibrosis
US$ 27.54
US$ 27.10
US$ 25.03
